Skip to content

Study on analgesia after thoracoscopic lobectomy

Study on analgesia after thoracoscopic lobectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036317
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

PCEA:epidural analgesia
L-PCIA:local anesthesia combined with patient-controlled intravenous analgesia
I-PCIA:preoperative single intercostal nerve block combined with patient-controlled intravenous analgesia
P-PCIA:preoperative single paravertebral block combined with patient-controlled intravenous analgesia

Sponsors

The Affiliated Hospital of Inner Mongolia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients underwent thoracoscopic lobectomy at the Affiliated Hospital of Inner Mongolia Medical University, ASA II to III, aged 18 years or older, diagnosed or suspected of early stage lung cancer

Exclusion criteria

Exclusion criteria: Spinal disease/surgical history (abnormality, lumbar disc herniation, vertebral compression fracture, thoracolumbar pain, history of spinal surgery, etc.), coagulopathy, severe pleurisy found during surgery, history of drug allergy, puncture site infection, within 3 months Participated in other clinical studies, the investigators believe that any reason is not suitable for this test, sepsis / sepsis, central / peripheral neurological disease, intracranial hypertension, intraspinal tumor or other lesions.

Design outcomes

Primary

MeasureTime frame
postoperative early rehabilitation;

Secondary

MeasureTime frame
Chronic pain;postoperative acute pain;

Countries

China

Contacts

Public ContactZHANG Jing

Department of Anesthesiology, The Affiliated Hospital of Inner Mongolia Medical University

1016077524@qq.com+86 15904814708

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026